The Node’s core will be on the Queen Elizabeth University Hospital campus in the new Laboratory Medicine building, which with its 2000-bed hospital, is the largest in Europe. The Pathology Department provides comprehensive Histopathology and Cytopathology services, including Paediatric and Neuropathology and processes around 100,000 histopathology requests and 20,000 non-gynaecological cytopathology requests annually. Molecular diagnostics is beside Pathology, and offers a regional and Scottish national service, testing over 30,000 specimens annually. The Molecular Diagnostics Laboratory is accredited by Clinical Pathology Accreditation (CPA) UK and possesses hardware and software to deliver Next Generation Sequencing (NGS). NHSGGC supports molecular pathology, from clinical services to R&D-funded facilities including NHS Informatics, the Safe-Haven, and the Biorepository. NHSGGC is fully committed to supporting the Node, including:

  • Full support of the Heath Records and Informatics directorate in developing integrated systems for clinical and molecular pathological records.
  • Access through our well established governance framework to our comprehensive electronic health records.
  • Full support of our expert pathology staff and access to our extensive, state-of-the-art laboratory facilities.
  • Expertise of the R&D directorate in regulatory aspects and legal/ contractual issues involving the NHS.
  • Full access to the clinical community across the health board’s locations.

The close links between the Glasgow Molecular Pathology Node and NHSGG&C will enable improved clinical practice in molecular pathology in the UK and beyond. The molecular diagnostics and approaches developed will drive beneficial change in clinical practice for patients worldwide and industry partners will benefit from the commercial exploitation of these diagnostics and approaches.